Polar Capital Funds PLC - Biotechnology Fund S Inc (EUR)Register to Unlock Ratings |
Performance History | 30/06/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
![]() | Fund | 36.7 | 5.9 | 4.9 | 10.0 | 6.6 |
![]() | +/-Cat | 10.8 | 14.9 | 12.7 | 11.3 | 7.2 |
![]() | +/-B’mrk | 3.8 | 5.6 | 2.4 | 2.7 | -11.2 |
Category: Sector Equity Biotechnology | ||||||
Category Benchmark: Morningstar Gbl Biotechnolo... |
Key Stats | ||
NAV 15/07/2024 | EUR 47.65 | |
Day Change | 0.31% | |
Morningstar Category™ | Sector Equity Biotechnology | |
ISIN | IE00BF23BX13 | |
Fund Size (Mil) 12/07/2024 | USD 1919.33 | |
Share Class Size (Mil) 12/07/2024 | USD 17.83 | |
Max Initial Charge | 5.00% | |
Ongoing Charge 30/06/2024 | 0.87% |
Investment Objective: Polar Capital Funds PLC - Biotechnology Fund S Inc (EUR) |
The investment objective of the Fund is to preserve capital and achieve long term capital appreciation. |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
David Pinniger 31/10/2013 | ||
Gareth Powell 31/10/2013 | ||
Inception Date 31/10/2013 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
NASDAQ Biotechnology NR USD | Morningstar Gbl Biotechnology NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Polar Capital Funds PLC - Biotechnology Fund S Inc (EUR) | 31/05/2024 |
|
|
Top 5 Holdings | Sector | % |
![]() | ![]() | 7.39 |
![]() | ![]() | 5.26 |
![]() | ![]() | 5.02 |
![]() | ![]() | 4.81 |
![]() | ![]() | 4.44 |
![]() | ||
![]() ![]() ![]() | ||
Polar Capital Funds PLC - Biotechnology Fund S Inc (EUR) |